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Background: The aim of this study was to investigate cytokine levels in the masseter muscle, their response to
experimental tooth-clenching and their relation to pain, fatigue and psychological distress in patients with
temporomandibular disorders (TMD) myalgia.
Methods: Forty women, 20 with TMD myalgia (Diagnostic Criteria for TMD) and 20 age-matched healthy controls
participated. Intramuscular microdialysis was performed to sample masseter muscle cytokines. After 140 min
(baseline), a 20-minute tooth-clenching task was performed (50% of maximal voluntary contraction force). Pain
(Numeric rating scale 0–10) and fatigue (Borg’s Ratings of Perceived Exertion 6–20) were assessed throughout
microdialysis, while pressure-pain thresholds (PPT) were assessed before and after microdialysis. Perceived stress
(PSS-10) and Trait Anxiety (STAI) were assessed before microdialysis.
Results: The levels of IL-6, IL-7, IL-8 and IL-13 were higher in patients than controls (Mann Whitney U-test; P’s < 0.
05) during the entire microdialysis. IL-6, IL-8 and IL-13 changed during microdialysis in both groups (Friedman;
P’s < 0.05), while IL-1β, IL-7 and GM-CSF changed only in patients (P’s < 0.01). IL-6 and IL-8 increased in response
to tooth-clenching in both groups (Wilcoxon test; P’s < 0.05), while IL-7, IL-13 and TNF increased only in patients
(P’s < 0.05). Patients had higher pain and fatigue than controls before and after tooth-clenching (P < 0.001), and
lower PPTs before and after microdialysis (P < 0.05). There were no correlations between cytokine levels, pain or
fatigue. Also, there were no differences in stress or anxiety levels between groups.
Conclusions: In conclusion, the masseter levels of IL-6, IL-7, IL-8 and IL-13 were elevated in patients with TMD
myalgia and increased in response to tooth-clenching. Tooth-clenching increased jaw muscle pain and fatigue, but
without correlations to cytokine levels. This implies that subclinical muscle inflammation may be involved in TMD
myalgia pathophysiology, but that there is no direct cause-relation between inflammation and pain.
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Temporomandibular disorders (TMD) are the most
common chronic pain conditions in the orofacial region,
affecting approximately 10–15% of the adult population
[1] and twice as many women as men [2]. The most
common subtype is TMD myalgia with jaw muscle pain
that is increased by function, pain on palpation, pain re-
ferral, restricted mouth opening, and headache [3, 4].
The etiology of TMD and the higher prevalence among
women is not well understood.* Correspondence: sofia.louca@ki.se
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the Creative Commons license, and indicate ifOne hypothesis is that excessive tooth-clenching/
grinding might contribute by disturbing the local blood
flow in overloaded muscles, leading to ischemia [5]. Epi-
demiological studies show greater odds of having TMD
myalgia when self-reported tooth-clenching is present
[6–8]. Ischemia releases neuroactive and inflammatory
biomarkers, such as neuropeptides, bradykinin, protons,
serotonin (5-HT), glutamate and cytokines that may
activate and sensitize nociceptors on peripheral sensory
afferents to induce muscle pain and allodynia [9, 10]. Re-
peated muscle activity may then maintain chronic
muscle pain by temporal summation [11]. Previous stud-
ies have shown that intense chewing induced pain and
fatigue in pain-free healthy participants with similar, butis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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This observation may suggest that, at least a subset of
M-TMD pain patients could be more alike an exercise-
induced muscle pain probably caused by ischemia and an
accumulation of metabolic biomarkers in the masticatory
muscles [12–14]. In another study, experimental tooth-
clenching increased jaw muscle pain in patients with
M-TMD and caused low levels of pain in controls.
Patients with M-TMD had higher levels of 5-HT during
the entire experiment, but did not increase in response to
tooth-clenching, suggesting that other algesic substances
might be released and activate nociceptors that are most
likely already sensitized by 5-HT [15].
Studies have shown that several cytokines play a role
in acute inflammatory muscle pain and in some chronic
muscle pain conditions. There are both pro- and anti-
inflammatory cytokines interacting with each other in a
balanced matter in order to fight an infection and pro-
mote wound healing, and they are often released in a
cascade in response to tissue damage. The pro-
inflammatory cytokines can initiate an inflammatory
response by recruiting other cytokines, macrophages,
t-cells and b-cells, initiating the inflammatory response,
while anti-inflammatory cytokines can reduce and pro-
mote healing by controlling the cytokine response [16].
For example, patients with various chronic pain condi-
tions (neuropathic, nociceptive and mixed pain) had
higher serum level of interleukin (IL)-6, IL-1β, IL-2,
tumor necrosis factor (TNF), and interferon gamma
(IFN-γ) than healthy controls, which correlated with
pain intensity [17], and increased cerebrospinal fluid
(CSF) and plasma level of IL-8 were reported in patients
with widespread pain [18, 19]. In patients with TMD
pain increased levels of IL-1β, IL-6, IL-10, TNF, IL-1ra,
and monocyte attractant protein-1 (MCP-1) have been
reported [19, 20].
Also, muscle levels of TNF and IL-1β were increased
in trapezius trigger points in patients with myofascial
pain [21, 22], and IL-6 increased in the painful trapezius
muscle of patients with whiplash-associated disorders
(WAD) [23]. Muscle and plasma levels of IL-6 and IL-8
increase in response to exercise [24, 25]. However,
serum IL-10 showed a blunted response to exercise in
fibromyalgia [26].
Regardless of their potential role in the development
and maintenance of some chronic pain conditions, little
is known about the peripheral involvement of cytokines
in TMD myalgia. The aim of this study was therefore to
compare the levels of the pro- and anti-inflammatory
cytokines IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10,
IL-12, IL-13, TNF, IFN-γ, and GM-CSF in the masseter
muscle between TMD myalgia patients and healthy con-
trols and the effects of a repetitive tooth-clenching task
on their release and relation to masseter pain intensity,fatigue, and pressure-pain thresholds (PPT). Further-
more, perceived stress and anxiety may also be involved
in the pathophysiology of TMD pain [27]. Therefore,
questionnaires were used to estimate the potential cor-
relation between biomarkers and psychological variables.
We hypothesized that muscle level of the cytokines
would be higher in patients than controls, increase in
response to a repetitive tooth-clenching task in a similar
manner in both groups, and correlate to pain intensity,
fatigue and level of stress and anxiety.
Methods
Participants
Twenty women with TMD myalgia and twenty age-
matched healthy women were included. Participants
were recruited by advertisements and among colleagues
and students at the Department of Dental Medicine at
the Karolinska Institutet, Huddinge, Sweden where the
study was performed. Inclusion criteria for the patients
were age over 18, a diagnosis of myalgia according to
the Diagnostic Criteria for TMD (DC/TMD) [1] and
pain lasting for over 3 months. Inclusion criteria for the
controls were age over 18, good general health and no
history of/or current pain from the orofacial region. Ex-
clusion criteria for both groups were systemic muscular
or joint diseases, WAD, neuropathic pain or neurological
disorders, pain of dental origin, and use of analgesics of
non-steroidal anti-inflammatory drugs during 48 h
before microdialysis.
Based on a previous study [15, 28] the power calcula-
tion showed that inclusion of 20 participants in each
group would be sufficient to detect a significant differ-
ence of 20% (SD 30%) in biomarker levels with 80%
power and a significance level of 5%.
The study followed the guidelines of the Declaration
of Helsinki and was approved by the Regional Ethical
Review Board in Stockholm (2009/2047-32), Sweden. All
participants were given written and verbal information
before participating and gave their written consent. The
participants were compensated upon completion of their
participation.
Experimental protocol
The study used a case–control design with one session
lasting for 220 min. After inclusion, psychological dis-
tress was assessed; thereafter the maximal voluntary
clenching force (MVCF), and PPT were recorded. Partic-
ipants were reclined in a conventional dental chair and
instructed to lie as still as possible during the experi-
ment and to avoid talking. After baseline registrations
and local anesthesia, microdialysis was performed in one
of the masseter muscles. After 120-minutes (trauma
phase), baseline assessments of pain intensity and fatigue
were made (120–140 min), followed by a 20-minute
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assessed after tooth-clenching. After an additional hour
(recovery) the microdialysis catheter was removed and
the PPTs were again assessed (Fig. 1).
Experimental tooth-clenching
MVCF (kg) was assessed with a bite-force transducer
(Aalborg University, Denmark) placed between the mo-
lars on the most suitable side, from a dental point of
view. The same side was used for the clenching task and
microdialysis. Participants were instructed to bite as
hard as possible on the bite-force transducer for 2–3 s.
The mean of three MVCF registrations was calculated.
During the experimental tooth-clenching, participants
were instructed to repeatedly bite 50% of their mean
MVCF for 30-seconds followed by 30-seconds of rest
during 20-minutes [15]. Visual feedback was used to
maintain the clenching level.
Assessments of pain intensity, fatigue and pressure-pain
threshold
A 0–10 numerical rating scale (NRS) was used to assess
pain intensity in the masseter muscle every 20th minute
during microdialysis. The Borg Rating of Perceived Exer-
tion Scale (6–20; RPE) was used to measure fatigue [29].
PPT was assessed with an electronic pressure alg-
ometer (Somedic Sales AB, Höör, Sweden) with a stan-
dardized pressure rate of 50 kPa/s. The tip of the device
was 1 cm2, covered with a 1-mm thick rubber-pad. PPT
was recorded by applying pressure on the most promin-
ent point of the masseter muscle during contraction,
and on the right index finger, which was used as anFig. 1 Flow chart of the experimental setting. The figure shows the time p
MVCF (kg), questionnaires (STAI and PSS-14), pain intensity (NRS), fatigue (B
tooth-clenching in 20 women with temporomandibular disorder myalgia (P
DC/TMD = Diagnostic criteria for TMD; STAI = State-Trait Anxiety Inventory;extra-cranial reference point. Participants pressed a
signal-button when the sensation of pressure turned into
pain [30]. The mean of three registrations was used in
statistical analyzes.
Psychological distress
The Swedish version of the State-Trait Anxiety Inven-
tory (STAI) was used to assess trait-anxiety. It contains
twenty questions measuring the levels of anxiety as a
personal characteristic. Scores ranges from 20 to 80,
where high scores (>30) indicate higher levels of
anxiety [31, 32].
Stress levels were measured with the Swedish version
of the Perceived Stress Scale-14 (PSS-14) consisting of
14 stress-related questions of a general nature, including
feelings and thoughts during the last month, situations
in life that are perceived as stressful, and the current
level of experienced stress. The total scoring is 56, and
scores below 23.67 are considered normal in healthy
participants [33, 34].
Microdialysis
The most prominent point of the masseter muscle, veri-
fied by palpation during contraction, was chosen for
microdialysis. The skin overlying the muscle was anaes-
thetized with a local injection (0.5 ml) of Lidocaine
(Xylocaine 20 mg /ml), carefully avoiding anaesthetizing
the underlying muscle.
A sterile split able introducer (CMA Microdialysis AB,
Solna, Sweden) was inserted intramuscularly in parallel
to the muscle fibers at a 45-degree angle to a depth of
approximately 40 mm from the skin surface [15, 35].oints (minutes) for the clinical examination (DC/TMD), assessment of
org scale), pressure pain threshold (PPT), microdialysis sampling and
atients) and 20 pain-free healthy aged-matched women (Controls).
PSS = Perceived Stress Scale
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typically felt upon penetration of the muscle fascia, and
the introducer was additionally inserted 20 mm. A sterile
100 kDa 60 mm long microdialysis catheter with 20 mm
membrane length (CMA71 Microdialysis AB, Solna,
Sweden) was inserted to the full length, thereafter the
introducer was removed by splitting the plastic tube.
The catheter was perfused (5 μL/ min) with a Ringer-
Acetate solution (Pharmacia & Upjohn, Copenhagen,
Denmark) containing 3 mmol glucose and 0.5 mmol lac-
tate from a 2-ml syringe connected to a micro-infusion
pump (CMA107, Microdialysis AB, Solna, Sweden).
Samples (100 μL) were collected every 20-minutes in
capped microvials and immediately frozen (−80 °C).
After microdialysis, the catheter was removed and the
membrane was checked to ensure that no damaged had
occurred.
Analyzes of dialysate
The cytokines were analyzed with Luminex technology
using multiplex immunoassay panels (Milliplex®map kit,
Human High sensitivity, T-cell magnetic bead panel, 96-
well plate assay, Merck Millipore Darmstadt, Germany)
in accordance to the manufacturer’s manual.
The limit of detection (LOD) for each cytokine re-
spectively were for IL-1β, IL-2, IL-5, and IL-12: 0.49 pg./
mL; IL-4: 1.83 pg./mL; IL-6: 0.18 pg./mL; IL-7: 0.37 pg./
mL; IL-8: 0.31 pg./mL, IL-10: 1.46 pg./mL; IL-13:
0.24 pg./mL; GM-CSF: 1.22 pg./mL; IFN-γ: 0.61 pg./mL
and for TNF: 0.43 pg./mL.
For each cytokine the number of samples with levels
below LOD were calculated. As a quality control, cyto-
kines with >50% of samples below LOD were excluded
from further analysis. This was based on findings from
our group that some cytokines are undetectable in many
individuals, making the results difficult to interpret
(Ernberg et al, personal communication). Others have used
similar approaches, although with less strict criteria [36].
Statistics
Data were analyzed with SigmaPlot for Windows, ver-
sion 11 (Systat Software Inc. Chicago, IL, USA) and
STATISTICA, StatSoft Dell Software version 12.0
(Round Rock, Texas USA). For descriptive statisticsTable 1 Dialysate samples with cytokines levels below LOD
IL-1β IL-2 IL-4 IL-5 IL-6 IL-7 IL
All 75 (19.1) 268 (68.4) 291 (74.2) 264 (67.3) 68 (17.3) 133 (33.9) 45
Patients 54 (24.3) 133 (59.9) 188 (84.7) 144 (64.9) 38 (17.1) 82 (36.9) 18
Controls 21 (12.4) 135 (79.4) 103 (60.6) 120 (70.6) 30 (17.6) 51 (30.0) 27
Table show the dialysate samples with cytokines levels below LOD in 20 wom
pain-free healthy aged-matched women (Controls). Data are presented as n =
LOD Limits of detection, IL Interleukin, TNF Tumor necrosis factor, IFN Interfero
figures denote cytokines with 50% of the samples below LOD (excluded frommean and standard deviation (SD) or median and inter-
quartile range (IQR) were used. Non-parametric statis-
tics were used since most cytokines were not normally
distributed and attempts to transform data did not
change this. To analyze differences in cytokine levels
between groups, the average of all 11 dialysate samples
(0–220 min) was calculated and compared with Mann-
Whitney U-test. Friedman-test was used to analyze
changes in cytokine levels over time. Wilcoxon-test
compared the time points 140 min (BL) and 160–
220 min within groups. Cytokine, pain and fatigue levels
after clenching (160 min) were compared between groups
with Mann-Whitney U-test. Spearman correlations-test
with Bonferroni correction for multiple testing was used
to analyze correlations between cytokine levels, pain, fa-
tigue and psychological distress. Differences in STAI-trait
and PSS-14 scores between groups and differences in
PPTs between sides before and after microdialysis
were analyzed with unpaired t-test. The level of
significance was P < 0.05.
Results
Cytokine levels
IL-2, IL-4, IL-5, IL-10 and IFN-γ were excluded from
further statistical analysis since more than 50% of the
samples were below LOD (Table 1).
The dialysate levels of the cytokines are shown in Table 2
and Fig. 2. The dialysate levels of IL-6, IL-7, IL-8, and IL-
13 were higher in patients than controls during the entire
microdialysis. IL-6, IL-8 and IL-13 changed during micro-
dialysis in both groups, while IL-1β, IL-7 and GM-CSF
changed only in patients. IL-6 and IL-8 increased in
response to tooth-clenching in both groups, while IL-7,
IL-13 and TNF only increased in the patients. There were
no significant differences in cytokine levels between
patients and controls after tooth-clenching (160 min).
Pain intensity and levels of fatigue
Patients had higher baseline pain intensity and fatigue
than controls. Tooth-clenching increased pain intensity
in patients and evoked mild pain in controls. It also
increased fatigue in both groups (Table 3).
There were no significant correlations between cyto-
kines levels and other variables (P > 0.102; rs < 0.384).-8 IL-10 IL-12 IL-13 TNF IFN-γ GM-CSF
(11.5) 210 (53.6) 180 (45.9) 140 (35.7) 169 (43.1) 319 (81.4) 178 (45.4)
(8.1) 118 (53.1) 127 (57.2) 64 (28.8) 100 (45.0) 165 (74.3) 118 (53.2)
(15.9) 92 (53.6) 53 (31.2) 76 (44.7) 69 (40.6) 154 (90.6) 60 (35.3)
en with Temporomandibular Disorders myalgia (Patients) and 20
number of undetectable dialysate samples (%)
n, GM-CSF Granulocyte macrophage colony-stimulating factor. Bold
further analyses)
Table 2 The average cytokine levels for all samples combined
IL-1β IL-6 IL-7 IL-8 TNF GM-CSF IL-12 IL-13
Dialysate levels
Patients 2.3 (7.0) 25.8 (42.3) 11.4 (21.5) 36.2 (51.4) 4.4 (8.8) 10.1 (11.2) 5.5 (11.8) 4.1 (5.9)
Controls 1.6 (2.3) 11.0 (12.6) 6.4 (3.2) 10.1 (14.7) 3.5 (1.5) 14.8 (23.3) 7.4 (3.0) 9.7 (13.4)
P-values 0.208 0.015 0.041 0.002 0.291 0.199 0.507 0.002
The average cytokine levels for all samples combined (0–220 min) in 20 women with Temporomandibular Disorders myalgia (Patients) and 20 pain-free healthy
age-matched women (Controls). Data are presented as median (IQR)
IQR interquartile range (75 percentile minus 25 percentile), IL Interleukin, TNF Tumor necrosis factor, GM-CSF Granulocyte macrophage colony-stimulating factor.
Bold italic figures denote significant group differences (P < 0.05)
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Baseline characteristics of the participants and PPT be-
fore and after microdialysis are shown in Table 4. There
were no differences between groups in PSS-14 or STAI-
trait levels, but the MVCF was lower in patients than
controls. PPT over the masseter muscles were lower in
patients than controls, in contrast to the reference
point, but had not changed after microdialysis in any
group (Table 4).
Discussion
The main findings were that the masseter levels of IL-6,
IL-7, IL-8 and IL-13 were higher in TMD myalgia patientsFig. 2 The levels of cytokines during microdialysis. Graph showing the leve
temporomandibular disorder myalgia (Patients) and 20 pain-free healthy ag
repetitive tooth-clenching task (140–160 min) was performed followed by
(P = 0.012), IL-8 (P < 0.001), IL-13 (P < 0.001), and GM-CSF (P = 0.008) increase
and IL-13 (P = 0.042) increased with time in the controls (Friedman test). IL-
increased after clenching (160 min) compared to baseline (140 min) in the
controls (Wilcoxon test). There were no significant differences in cytokine le
there was a trend for IL-8 (Mann-Whitney U-test, P = 0.074). *= significant dthan controls and that repetitive tooth-clenching in-
creased the levels of IL-6 and IL-8 in both groups, while
IL-7, IL-13 and TNF increased only in patients. Also,
tooth-clenching evoked higher pain intensity and fatigue
in TMD myalgia patients than controls. Finally, there were
no correlations between pain, fatigue and cytokine levels.
Overall, the results from this study supports the hy-
potheses that 1) the muscle levels of pro- and anti-
inflammatory cytokines appear to be elevated in TMD
myalgia and 2) severally pro- and anti-inflammatory
cytokines increased after repetitive tooth-clenching in
both groups. However, there were no significant differ-
ences between TMD myalgia patients and controls. Thisls of cytokines (mean and SEM) during microdialysis in 20 women with
ed-matched women (Controls). After 140 min (baseline), a 20-minute
one-hour rest (160–220 min). IL-1β (P = 0.0007), IL-6 (P < 0.001), IL-7
d with time in the patients, whereas IL-6 (P < 0.001), IL-8 (P < 0.001),
6 (P < 0.001), IL-8 (P = 0.001), IL-13 (P = 0.035), and TNF (P = 0.042) had
patients, and IL-6 (P = 0.004) and IL-8 (P = 0.032) had increased in the
vels between patients and controls after clenching (160 min), although
ifference between the groups (P < 0.05)
Table 3 The median (IQR) pain intensity (NRS) and fatigue
(Borg RPE) in the masseter muscle
Before After P-values
Pain
Patients 3 (3) 7 (3) <0.001
Controls 0 (0) 0 (2) 0.016
P-values between groups <0.001 <0.001
Fatigue
Patients 13 (4) 19 (1) <0.001
Controls 6 (0) 14 (3) <0.001
P-values between groups <0.001 <0.001
Table show the median pain intensity and fatigue before and after a 20-minute
tooth-clenching task in 20 women with Temporomandibular Disorders myalgia
(Patients) and 20 pain-free healthy age-matched women (Controls). IQR
interquartile range (75 percentile minus 25 percentile), NRS Numeric rating scale
(0–10), Borgs’s RPE Borg’s ratings of perceived exertion scale (6–20). Bold italic
figures denote significant differences (P < 0.05)
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drive chronic muscle pain. However, 3) no correlations
with pain, fatigue or PPT levels were found, so in future
studies the balance and interaction between pro- and
anti-inflammatory cytokines as well as other inflamma-
tory mediators need to be considered.
This is the first study to show elevated muscle levels
of the pro-inflammatory cytokines IL-6 and IL-8 and theTable 4 Baseline characteristics in 20 women with
Temporomandibular Disorders myalgia and 20 healthy pain-free
age-matched women
Patients Controls P-values
Age (yr) 31 (10) 29 (11)
MVCF (kg) 356 (205) 469 (113) 0.018
STAI-trait (20–80) 42 (19) 36 (10) 0.321
PSS-14 (0–56) 23 (15) 20 (9) 0.392
PPT (kPa)
Before
Experimental side 160 (±70) 239 (±62) 0.003
Control side 163 (±46) 230 (±30) <0.001
P-values between sides 0.876 0.570
Reference point 412 (±131) 384 (±115) 0.573
After
Experimental side 124 (±71) 232 (±52) <0.001
Control side 147 (±66) 234 (±48) <0.001
P-values between sides 0.298 0.919
Reference point 454 (±273) 425 (±94) 0.741
The baseline characteristics as well as pressure pain thresholds (PPT) before
and after microdialysis are shown
Data are presented as median (IQR) or mean (±SD). IQR interquartile range
(75 percentile minus 25 percentile), SD Standard deviation, MVCF Maximum
voluntary contraction force, STAI State- and trait anxiety inventory, PSS
Perceived stress scale. Bold italic figures denote significant
differences (P < 0.05)anti-inflammatory cytokines IL-7 and IL-13 in painful
jaw muscles of patients with TMD myalgia which sup-
ports the hypothesis that patients with TMD myalgia
have higher levels of cytokines. The results are partly
consistent with previous results in other localized myal-
gias showing increased IL-6 in the painful trapezius
muscle of WAD patients [23] and IL-1β and TNF in
myofascial trapezius trigger points [21, 22], although one
early study did not find any difference in trapezius levels
of IL-6 between patients with chronic trapezius myalgia
and controls [37]. They are also consistent with very re-
cent results showing that lipopolysaccharide (LPS) stim-
ulated monocytes from patients with TMD show an
enhanced production of IL-1β, TNF and IL-6 [38]. Pro-
inflammatory cytokines may act directly on nociceptor
terminals to induce pain [39]. Increased muscle levels of
other inflammatory markers, such as serotonin and glu-
tamate have also been reported in chronic localized my-
algia [15, 23, 35]. These results combined gives support
for the involvement of peripheral mechanisms in local-
ized chronic myalgia, and may implicate that patients
with chronic pain constantly have their immune system
switched on with higher levels of inflammatory media-
tors leading to peripheral sensitization, which may drive
central sensitization processes and pain [40]. The in-
creased muscle levels of IL-7 and IL-13 in the patients
in this study imply that anti-inflammatory cytokines are
locally produced to counteract this effect, although this
may not be sufficient as LPS-stimulated monocytes from
TMD-patients showed a blunted response of IL-10 [38].
In patients with TMD elevated plasma levels of both
pro- (IL-1β, IL-6, TNF) and anti-inflammatory (IL-10)
cytokines were recently reported [20]. Contrary, in TMD
patients with widespread pain and in fibromyalgia
plasma levels of pro-inflammatory IL-8 were higher
[18, 19, 41] and IL-10 lower than controls [18]. This
suggests that the balance between pro- and anti-
inflammatory cytokines may differ between TMD with
and without widespread pain [19] and supports a shift
to a more pronounced central pro-inflammatory state
in widespread myalgia compared to localized myalgia.
Thus, peripheral sensitization may be of greater import-
ance in the pathophysiology of localized myalgias than
in widespread pain.
Tooth-clenching increased IL-6, IL-7, IL-8, TNF and
IL-13 in TMD myalgia patients and IL-6 and IL-8 in
controls, in line with previous studies [25, 37]. IL-6 and
IL-8 are regarded as myokines, i.e. cytokines that are
produced in the muscle [24], while TNF probably is
produced in other tissue [42]. Although plasma cyto-
kines were not analyzed in this study, muscle levels of
IL-6 and IL-8 (but not IL-1β or TNF) were reported
higher than plasma levels in patients with fibromyalgia,
supporting that they are produced in the muscle [25]. It
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response to exercise. Also, plasma levels of the anti-
inflammatory cytokines IL-4, IL-7, IL-10, and IL-13
seem to increase after exercise in healthy subjects [43]
and IL-10 also in patients with knee-osteoarthritis [44].
On the contrary, in patients with fibromyalgia, plasma
IL-10 showed a blunted response and IL-8 seem to de-
crease [26, 45]. Thus, patients with localized pain may
be able to recruit an anti-inflammatory response after
exercise in contrast to patients with generalized pain.
The repetitive tooth-clenching task evoked pain in the
controls and increased fatigue in both groups, with higher
intensities in TMD myalgia patients in accordance to pre-
vious studies using the same methodology [15, 30]. How-
ever, other mechanisms than release of cytokines are most
probably responsible for this as there were no correlations
between the release of cytokines on one hand, and pain or
fatigue on the other. This indicates that there is no direct
cause-effect relation between pain and cytokine levels.
Indeed, the increased pain level may be an effect of the
release of other biomarkers [35, 46] or interactions
between several other mechanisms [47].
Pain on palpation, reflecting muscle allodynia, is one
of the key symptoms of chronic muscle pain why it was
not surprising that PPT were lower in patients than con-
trols. Allodynia is generally regarded a sign of central
sensitization [48], but peripheral sensitization may par-
ticipate to the lowered PPT, as there were no differences
between TMD myalgia patients and controls in PPT over
the reference point. However, masseter PPT did not
change in response to tooth-clenching and did not correl-
ate with cytokine levels. This could be the reason why the
influence of muscle cytokines on muscle allodynia in
TMD myalgia is probably minor, if any at all.
Limitations and strengths
This is, to our knowledge, the first study investigating
the interstitial jaw-muscle release of cytokines in TMD
myalgia. Another strength is that a panel with 13 pro-
and anti-inflammatory cytokines was used for the ana-
lysis in the same dialysate samples so that differences in
their pattern after tooth-clenching could be analyzed.
One limitation was that some cytokines were under
LOD and had to be excluded. Yet, the most common cy-
tokines reported in previous microdialysis studies could
be detected. There are several factors that can affect the
dialysate levels, such as the flow-rate, the diffusion-rate
through the tissue, the area and weight cut-off of the
dialysis membrane, and the composition of the perfusate
[49]. Perhaps by adding a colloid to the ringer-solution,
the cytokines under LOD could have been detected [50].
Another limitation was that the relative recovery was
not analyzed, which could have provided a true value of
the extracellular concentrations. Furthermore, thepatients with TMD myalgia were quite young and had a
low average pain intensity at baseline, and may therefore
not fully represent the general TMD myalgia population.
However, the variability in pain intensity and age differs
in experimental studies of TMD patients with myalgia.
The data in our study is in accordance with findings of a
previous study [51]. Finally, the sample was limited only
to women that were psychologically healthy why it is
unclear if the results can be generalized to male patients
and patients with more severe psychological co-morbidities.Conclusion
This study showed that the muscle levels of IL-6, IL-7, IL-
8 and IL-13 were increased in patients with TMD myalgia
and increased further in response to experimental tooth-
clenching, as did jaw-muscle pain and fatigue. This give
further support that muscle inflammation may drive
chronic myalgia, but that patients with TMD myalgia have
a normal anti-inflammatory response to exercise. How-
ever, the lack of correlation between pain and cytokine
levels, indicates that there is no direct cause-relation effect
between increased pain and cytokine release and that
other peripheral mediators and mechanisms, such as
central sensitization are important for pain mediation.
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